Aion Therapeutic Inc.
ANTCF
OTC PK
10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | |
---|---|---|---|---|---|
Net Income | -187.80K | -191.10K | -534.10K | -160.00K | -481.20K |
Total Depreciation and Amortization | -- | -- | 100.00 | 4.30K | 4.40K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 23.50K | 23.90K | 474.80K | -70.00K | 407.10K |
Change in Net Operating Assets | 61.40K | 62.50K | 171.20K | 136.80K | 75.70K |
Cash from Operations | -102.90K | -104.70K | 111.90K | -88.90K | 6.00K |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 100.30K | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -98.00K | -99.70K | -- | -- | -- |
Cash from Investing | -98.00K | -99.70K | 0.00 | 100.30K | -- |
Total Debt Issued | -- | -- | 1.00K | 18.40K | 79.20K |
Total Debt Repaid | -- | -- | -100.00 | -141.70K | -6.40K |
Issuance of Common Stock | 271.30K | 271.30K | 0.00 | 0.00 | 100.00K |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 199.70K | 203.30K | 600.00 | -91.50K | 129.90K |
Foreign Exchange rate Adjustments | 1.30K | 1.30K | -112.30K | 70.00K | -138.50K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 200.00 | 200.00 | 200.00 | -10.00K | -2.60K |